RISA Labs has secured 11.1 million dollars in Series A funding co-led by Cencora Ventures and Optum...
The AMW Read
Updates the player map for oncology-focused Vertical AI (06) with a new entrant utilizing agentic workflows (02) to solve administrative bottlenecks.
NoveltySignificance
Healthcare & Bio Β· Player MapAI Agents Β· Definition
RISA Labs has secured 11.1 million dollars in Series A funding co-led by Cencora Ventures and Optum Ventures to scale its AI operating system for oncology. Its BOSS platform uses autonomous agents to manage complex workflows like prior authorizations across fragmented healthcare systems. By replacing manual paperwork with intelligent automation, the startup eliminates administrative bottlenecks that frequently delay life-saving treatments. This signifies a pivot toward AI agents that independently navigate payer ecosystems to optimize clinical operations. π
